EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Targeting BLyS and APRIL with Telitacicept versus Conventional Immunotherapy in Generalized Myasthenia Gravis: A Comparative Study

Yingying Yang, Nan Kang, Ying Zhu, Chi Ma, Ruixia Zhu

ImmunoTargets and Therapy · 2026-07 · Volume 15 · 1-13

DOI: 10.2147/itt.s616114 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ImmunoTargets and Therapy, 2026-07. Verfasst von Yingying Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital of China Medical University, Shenyang, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

B cellsanti-acetylcholine receptor antibodyconventional immunotherapygeneralized myasthenia gravistelitacicept

Autor:innen und Institutionen

  • Department of Neurology, The First Affiliated Hospital of China Medical University, Shenyang, People's Republic of China.
  • Key Laboratory of Neurological Disease Big Data of Liaoning Province, Shenyang, People's Republic of China.
  • Shenyang Clinical Medical Research Center for Difficult and Serious Diseases of the Nervous System, Shenyang, People's Republic of China.

Zitieren

APA

Yang, Y., Kang, N., Zhu, Y., Ma, C., & Zhu, R. (2026). Targeting BLyS and APRIL with Telitacicept versus Conventional Immunotherapy in Generalized Myasthenia Gravis: A Comparative Study. ImmunoTargets and Therapy, Volume 15, 1-13. https://doi.org/10.2147/itt.s616114

Vancouver

Yang Y, Kang N, Zhu Y, Ma C, Zhu R. Targeting BLyS and APRIL with Telitacicept versus Conventional Immunotherapy in Generalized Myasthenia Gravis: A Comparative Study. ImmunoTargets and Therapy. 2026;Volume 15:1-13. doi:10.2147/itt.s616114

BibTeX
@article{Yang2026,
  author = {Yang, Yingying and Kang, Nan and Zhu, Ying and Ma, Chi and Zhu, Ruixia},
  title = {Targeting BLyS and APRIL with Telitacicept versus Conventional Immunotherapy in Generalized Myasthenia Gravis: A Comparative Study},
  journal = {ImmunoTargets and Therapy},
  year = {2026},
  volume = {Volume 15},
  pages = {1--13},
  doi = {10.2147/itt.s616114}
}
Kostenlos starten →